Severe hindlimb lameness and pathological femur fracture in a horse secondary to haemangiosarcoma

An 18‐year‐old Warmblood stallion was presented for an acute onset nonweightbearing right hindlimb lameness following a mild lameness of 2 weeks' duration. Severe swelling was present in the right femoral area. Despite extensive diagnostic procedures, no definitive diagnosis could be made. Packed red cell volume was persistently low. The horse improved with supportive treatment and was discharged at the owner's request. The horse presented 4 days later for bleeding from a previously made incision on the lateral femoral area. Due to deterioration of his condition, the stallion was subjected to euthanasia. Diagnosis of disseminated haemangiosarcoma, affecting primarily the hindlimb musculature and leading to pathological fracture of the femur was made at necropsy and subsequent histopathology.     

Haemangiosarcoma in the horse

Neoplasms arising from vascular endothelial cells include benign haemangioma and malignant haemangiosarcoma, both of which are rare in the horse. Haemangiosarcoma can arise as a solitary mass, typically involving the eye or skin, or as disseminated tumours throughout multiple organs. There is no sex, breed or age predilection but most cases are found in middle aged horses. Clinical presentations of haemangiosarcoma in the horse include the presence of a visible mass or reflect dysfunction of the organ involved, thus making it difficult to differentiate from other neoplasms. Ante mortem diagnosis through clinicopathological findings, cytological findings of body cavity effusions or fine needle aspirates are often unrewarding. Biopsy or mass submission for histopathological examination may aid in diagnosis of haemangiosarcoma. A majority of cases are diagnosed post mortem; however, if the mass is poorly differentiated additional diagnostics such as immunohistochemical staining may be needed. Unfortunately, treatment of haemangiosarcoma is often unrewarding and limited based on the location of the mass and the aggressive nature of this neoplasm.     

Penile and preputial tumours in the horse: literature review and proposal of a standardised approach

Penile and preputial tumours are not uncommon in the horse, but can cause discomfort and lead to serious complications. Several types of tumour of the male external genitalia have been described. The most common type is the squamous cell carcinoma (SCC), which is found mainly in older horses. Reports of a breed predilection for penile tumour formation are equivocal, but castration, coat colour, poor hygiene and various infectious agents have all been suggested to predispose to the development of some types of tumour (e.g. SCC, papilloma and melanoma). Careful assessment of the primary tumour is an important first step in the design of an optimal treatment protocol. Invasiveness, differentiation grade, tumour size and presence of metastases are all relevant to the decision to pursue additional diagnostic procedures or specific treatment options. To date, no standard protocol has been reported for the approach to penile tumours in the horse and treatments range from minimally invasive therapies (e.g. topical use of 5-fluorouracil) to radical surgical interventions (e.g. en bloc penile and preputial resection with penile retroversion). Completeness of removal of the neoplasm and therefore risk of recurrence is highly dependent on the type of therapy chosen. However, the size and histopathological features of the primary tumour are also important factors with respect to the likelihood of recurrence. This review describes the most common penile and preputial neoplasms in the horse, and outlines a standard protocol aimed at arriving at a specific diagnosis and tailoring the therapeutic approach accordingly.     

Electronic brachytherapy used for the successful treatment of three different types of equine tumours

An electronic form of interstitial brachytherapy was used to treat tumours on 3 different horses. One horse was treated for an ocular lymphoma, the second for a sarcoid, and the third for melanoma. This form of brachytherapy contains inherent advantages over previously used forms of brachytherapy and provides another treatment option for equine tumours that cannot be treated with, or do not respond to, conventional tumour therapies.     

Lead toxicosis in the horse: A review

Lead intoxication is rarely diagnosed in horses and can present a major challenge to the equine practitioner because of the variety of clinical signs. Horses with lead poisoning can develop gastrointestinal disturbances, neurological abnormalities, haematological changes, or nonspecific signs of weight loss, weakness and rough hair coat, which makes early diagnosis difficult. Fortunately, lead analysis of whole blood is routinely available and can confirm intoxication. Because of the well‐described lead‐induced peripheral neuropathies in horses, a thorough neurological examination is essential in the investigation of a suspect case. Once diagnosed, the source of lead has to be identified and further exposure prevented. Intoxication can be treated by administering chelating drugs and providing symptomatic and supportive care.     

Initial experience with high dose rate brachytherapy of periorbital sarcoids in the horse

Periorbital sarcoids are a common condition in the horse and are difficult to treat due to their location and invasive nature. Radiotherapy is considered the gold standard treatment, and high dose rate brachytherapy (HDRB) may represent a safer and more effective method of delivering radiotherapy in the standing sedated horse. The objective of this retrospective clinical case series study was to describe the response rate and safety of HDRB for the treatment of periorbital sarcoids in the horse. Horses and ponies referred for HDRB treatment of confirmed periorbital sarcoids were eligible for inclusion in the study. Sarcoids were confirmed via clinical diagnosis and biopsy. Horses were given 2 fractions of 12.5 Gy per fraction, delivered a week apart, under standing sedation via a novel HDRB technique. Eight horses with periorbital sarcoids were treated with HDRB under standing sedation. A complete response occurred in all cases. No significant acute adverse effects were noted after treatment and the cosmetic result was excellent, with permanent epilation and leucotrichia the only long‐term sequelae. Follow‐up was available for between 10 and 12 months after treatment. The major limitation of this study is the lack of long‐term follow‐up and the small case numbers. It was concluded that HDRB appears to be an effective and safe method of treating periorbital sarcoids in the horse. Long‐term follow‐up is required to determine the risk of recurrence of treated lesions.     

Retrobulbar dermoid cyst in a horse: a case report

A 4-year-old Andalusian horse was presented for examination following a 3-month history of exophthalmos of the right eye and a soft swelling of the right supraorbital fossa noted after blunt head trauma. Ultrasonographic examination of the swelling showed an anecogenic mass of 5 cm in diameter involving the retrobulbar space. Centesis of the mass through the supraorbital fossa was performed and yielded a serous fluid with 7.2 g/dL of total protein and density of 1040. No cells were seen in the sample. A tentative diagnosis of cyst was made. The cyst was surgically removed and the definitive histologic diagnosis was retrobulbar dermoid cyst. No recurrence has developed 18 months following the complete removal of the cyst capsule. To the authors' knowledge, there are no previous reports of retrobulbar dermoid cysts in horses. Localization, causes and success of surgical treatment of dermoid cysts are discussed.     

Management of chronic airway inflammation in the horse: A systematic review

The purpose of this article is to review available scientific reports on recurrent airway obstruction and inflammatory airway disease treatment efficacy. Critical evaluation of the quality and limitations of the evidence provided should provide equine practitioners with the tools to apply the latest scientific data to the management of individual clinical cases. While a large body of clinical research supports the efficacy of low‐dust environmental management and corticosteroid administration in the treatment of recurrent airway obstruction, limited clinical trials exist to evaluate the treatment of inflammatory airway disease.     

Fatal equine meningoencephalitis in the United Kingdom caused by the panagrolaimid nematode Halicephalobus gingivalis: case report and review of the literature

A fatal case of eosinophilic and granulomatous meningoencephalitis caused by the free-living panagrolaimid nematode Halicephalobus gingivalis is reported in a 10-year-old Welsh gelding in the United Kingdom. Clinical examination first revealed behavioural abnormalities which rapidly progressed to severe ataxia, reduced mentation status and cranial nerve signs. Despite symptomatic treatment no amelioration of neurological signs was achieved and the horse was subjected to euthanasia. A complete post mortem examination revealed eosinophilic and granulomatous meningoencephalitis mainly affecting the cerebellum and brain stem with intralesional adult nematodes, larvae and eggs. There was also eosinophilic meningitis of the cervical spinal cord. The intralesional nematodes were morphologically consistent with the panagrolaimid nematode H. gingivalis. Although infection by this facultative neurotropic parasite is extremely rare, it needs to be considered in the differential diagnosis of central nervous signs in horses and, in particular, other equine helminthic infection of the central nervous system. This fatal case is unusual since lesions were locally very extensive and the nematodes did not colonise haematogenously to other organs as seen often in equine halicephalobosis. As the taxonomy of H. gingivalis has changed and some recent reports in the literature still refer to this species as Micronema deletrix or Halicephalobus deletrix, we here provide a short update of the species and some insights on the order Tylenchida, which contains free-living nematodes with parasitic tendencies.     

Interstitial lung fibrosis and emphysema in a standardbred horse: A case report

A horse with severe work-intolerance was examined. Neither clinical nor radiographic examination suggested the presence of emphysema and lung fibrosis.     

Ectopic ureter in the horse: Three cases and a review of the literature

Ureterovesicular anastomosis resulted in resolution of the clinical signs of urinary incontinence in three horses with unilateral ectopic ureter. Follow-up of two of the horses ten months and three years later indicated no further urinary tract problems; the third horse died four days after surgery from intestinal infarction.

Diagnosis can be readily confirmed by antegrade or retrograde ureterography, or endoscopic visualization of the ectopic ureteral openings. Nephrectomy appears indicated in cases of unilateral ectopic ureter with associated ipsilateral urinary tract infection or hydronephrosis, providing the contralateral kidney has normal function. Ureterovesicular anastomosis appears to be indicated in the management of unilateral ectopic ureters in the absence of ascending urinary tract infection or hydronephrosis, and in cases of bilateral ectopic ureters.

     

Evaluation of ataxia in the horse

Ataxia in the horse is a common clinical presentation requiring a methodical approach for accurate neurolocalisation. Observed neurological deficiencies should support a localised single aetiology whenever possible. Relevant differential diagnoses should be considered based on the case history and localisation. Diagnostic strategies can then be applied relative to disease risk.     

Equine castration: A review of techniques,complications and their management

Complications associated with castration occur commonly and, although the majority are mild and resolve easily, potentially life‐threatening complications can occur. The preoperative identification of risk factors for these complications can help the veterinarian to take the appropriate measures to reduce these risks. However, even with proper surgical technique, complications can occur. Therefore prompt recognition and initiation of appropriate therapy are essential to prevent further morbidity, death or lawsuits.     

Histiocytic sarcoma of macrophage origin in a cat: case report with a literature review of feline histiocytic malignancies and comparison with canine hemophagocytic histiocytic sarcoma

Mild nonregenerative anemia was detected in a 9-year-old neutered male domestic shorthair cat during a routine examination. Bone marrow core biopsy revealed erythroid hyperplasia; however, a specific cause was not identified. Over the next 8 months the anemia progressed, eventually becoming mildly regenerative, and moderate thrombocytopenia developed. On ultrasonographic examination, marked splenomegaly, mild hepatomegaly, and abdominal lymphadenopathy were found. Cytologic evaluation of splenic aspirates revealed increased numbers of mildly to moderately pleomorphic histiocytes that frequently had phagocytosed RBCs, leukocytes, and occasionally platelets. Histopathologic examination of the spleen and liver revealed effacement of splenic architecture by a histiocytic sarcoma (HS), and neoplastic histiocytes in hepatic sinusoids. A second bone marrow aspirate revealed neoplastic infiltration by similar cells. The histiocytes in all tissues were mildly to moderately pleomorphic and markedly erythrophagocytic. The immunophenotype of histiocytes in the spleen was CD1c(-)/CD11b(+)/CD18(+)/MHC-II(+), supporting a macrophage cell lineage. The clinical, pathologic, and immunophenotypic findings in this cat were similar to those in hemophagocytic HSs in dogs. To our knowledge, this is the first report of a HS of purported macrophage phenotype in a cat.     

Conservative management of comminuted central tarsal bone fracture and joint instability in a horse

A comminuted fracture of the central tarsal bone, fragmentation of the fourth tarsal bone and associated joint instability was diagnosed in a 14‐year‐old Sport Horse mare who presented for investigation of acute nonweightbearing hindlimb lameness. The mare responded well to conservative management and, unlike previously reported cases of similar injuries, returned to a similar level of athletic activity.     

Genetic diversity and inbreeding in the Greek Skyros horse

Inbreeding and heterozygosity levels were calculated in a population of 77 horses of the endangered Skyros breed that had been raised since 1988 at an experimental farm. Twenty one horses were inbred with average inbreeding coefficient of 0.11 ( ± 0.02). Annual inbreeding change over the last 10 years was not significant (P > 0.05). Animals were genotyped for 18 microsatellite markers. Average number of alleles was 4.11 ( ± 0.43). Average theoretical and observed heterozygosity were 0.63 ( ± 0.06) and 0.66 ( ± 0.06), respectively. The probability of paternity exclusion with 1 and 2 parents unconfirmed was 0.9890 and 0.9999, respectively. Genetic diversity levels were reasonable and comparable to results from other breeds internationally.